YMAB — Y-mAbs Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Y-mAbs Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	207	115	182	106	78.6
Net Total Accounts Receivable
Net Total Receivables	—	—	7.71	12.5	22.5
Total Inventory
Total Other Current Assets
Total Current Assets	212	122	202	130	111
Net Property, Plant And Equipment	4.04	6.39	5.69	2.34	1.64
Net Intangible Assets
Other Long Term Assets
Total Assets	216	132	213	141	128
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	13.6	19.5	27.9	28.3	20.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.5	26.2	32.7	32.2	26.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	199	106	180	109	101
Total Liabilities & Shareholders' Equity	216	132	213	141	128
Total Common Shares Outstanding